The E factor at 30: a passion for pollution prevention

RA Sheldon - Green Chemistry, 2023 - pubs.rsc.org
The introduction of the E Factor in 1992 focussed attention on the problem of waste
generation, defined as everything but the desired product, in chemicals manufacture and …

Shortening synthetic routes to small molecule active pharmaceutical ingredients employing biocatalytic methods

S Simić, E Zukić, L Schmermund, K Faber… - Chemical …, 2021 - ACS Publications
Biocatalysis, using enzymes for organic synthesis, has emerged as powerful tool for the
synthesis of active pharmaceutical ingredients (APIs). The first industrial biocatalytic …

Biocatalysis as key to sustainable industrial chemistry

AR Alcántara, P Domínguez de María… - …, 2022 - Wiley Online Library
The role and power of biocatalysis in sustainable chemistry has been continuously brought
forward step by step to its present outstanding position. The problem‐solving capabilities of …

Enzyme immobilization in hydrogels: A perfect liaison for efficient and sustainable biocatalysis

J Meyer, LE Meyer, S Kara - Engineering in Life Sciences, 2022 - Wiley Online Library
Biocatalysis is an established chemical synthesis technology that has by no means been
restricted to research laboratories. The use of enzymes for organic synthesis has evolved …

[HTML][HTML] Approved HIV reverse transcriptase inhibitors in the past decade

G Li, Y Wang, E De Clercq - Acta Pharmaceutica Sinica B, 2022 - Elsevier
HIV reverse transcriptase (RT) inhibitors are the important components of highly active
antiretroviral therapies (HAARTs) for anti-HIV treatment and pre-exposure prophylaxis in …

A selective and atom-economic rearrangement of uridine by cascade biocatalysis for production of pseudouridine

M Pfeiffer, A Ribar, B Nidetzky - Nature Communications, 2023 - nature.com
As a crucial factor of their therapeutic efficacy, the currently marketed mRNA vaccines
feature uniform substitution of uridine (U) by the corresponding C-nucleoside, pseudouridine …

Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches

V Asati, A Anant, P Patel, K Kaur, GD Gupta - European Journal of …, 2021 - Elsevier
Pyrazolopyrimidine scaffold is one of the privileged heterocycles in drug discovery. This
scaffold produced numerous biological activities in which anticancer is important one …

[HTML][HTML] Biocatalytic cascade transformations for the synthesis of C-nucleosides and N-nucleoside analogs

M Pfeiffer, B Nidetzky - Current Opinion in Biotechnology, 2023 - Elsevier
Highlights•Newly discovered enzymes possessing C-nucleoside synthase activity for
biocatalysis.•Multistep cascade reactions involving up to nine enzymes.•One-pot synthesis …

Advances in biocatalytic and chemoenzymatic synthesis of nucleoside analogues

SC Cosgrove, GJ Miller - Expert Opinion on Drug Discovery, 2022 - Taylor & Francis
Introduction Nucleoside analogues represent a cornerstone of achievement in drug
discovery, rising to prominence particularly in the fields of antiviral and anticancer discovery …

Biocatalytic strategy for the construction of sp3-rich polycyclic compounds from directed evolution and computational modelling

DA Vargas, X Ren, A Sengupta, L Zhu, S Roy… - Nature …, 2024 - nature.com
Catalysis with engineered enzymes has provided more efficient routes for the production of
active pharmaceutical agents. However, the potential of biocatalysis to assist in early-stage …